all - Opinion Summaries
Page 28 of 88
Showing Result 271 - 280 of 874
| Description | Date | Docket # |
|---|---|---|
People ex rel Strathmann v. Acacia Research Corp.California Court of Appeal
Constitutional Law, Drugs & Biotech, Insurance LawIn plaintiff's qui tam action alleging that his employer engaged in false and fraudulent insurance claims in connection with an on-going dispute with... |
10/24/2012 | G045390 |
Pozen Inc v. Par Pharmaceutical, Inc.United States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentIn plaintiff's suit for patent infringement and injunctive relief, judgment for plaintiff is affirmed where: 1) defendants failed to rebut the... |
09/28/2012 | 2011-1584 |
In re Abbott Diabetes Care, Inc.United States Federal Circuit
Patent, Drugs & Biotech, Intellectual PropertyIn an appeal from ex parte reexamination proceedings in which the Board of Patent Appeals and Interferences rejected Abbott's patent claims that... |
09/28/2012 | 2011-1516 |
Holmes v. Merck & Co., Inc.United States Ninth Circuit
Drugs & Biotech, Government Law, Health Law, Injury & Tort Law, Product LiabilityIn a wrongful death action against a manufacturer and distributor of a vaccine, arising out of the death of plaintiffs' infant son, the district... |
09/25/2012 | 08-16557 |
In re DrogeUnited States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentThe decision of the Board of Patent Appeals and Interferences affirming the rejection of claims of the '772 patent application, directed to methods of... |
09/21/2012 | 11-1600 |
Medtronic Inc. v. Boston Scientific Corp.United States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentIn a medical device and equipment manufacturer's suit seeking declaratory judgment of noninfringement and invalidity of patents related to a device... |
09/18/2012 | 11-1313 |
In re: Rigel Pharm., Inc. Securities LitigationUnited States Ninth Circuit
Corporation & Enterprise Law, Drugs & Biotech, Securities LawIn plaintiff's suit for securities fraud individually and on behalf of all other persons who purchased or otherwise acquired a pharmaceutical... |
09/06/2012 | 10-17619 |
Santarus, Inc. v. Par Pharm., Inc.United States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentIn a dispute over patents related to specified formulations of benzimidazole proton pump inhibitors, a class of chemical compounds that inhibit... |
09/04/2012 | 10-1360 |
Eli Lilly & Co. v. Teva Parental Medicines, Inc.United States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentIn a patent infringement suit related to applications filed by several generic pharmaceutical manufacturers seeking regulatory approval to market... |
08/24/2012 | 11-1561 |
Ass'n for Molecular Pathology v. U.S. Patent & Trademark OfficeUnited States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentOn remand from the U.S. Supreme Court in light of its decision in Mayo Collaborative Services v. Prometheus, Inc., the judgment of the district court... |
08/16/2012 | 10-1406 |
Results 271 to 280 of 874